comparemela.com

Latest Breaking News On - ஃபேபியன் ஸ்யூவாரெஸ் - Page 11 : comparemela.com

GERAL :: Nyxoah Reports Full Year 2020 Results – Medialab

GERAL :: Nyxoah Reports Full Year 2020 Results – Medialab
estadao.com.br - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from estadao.com.br Daily Mail and Mail on Sunday newspapers.

Nyxoah Reports Full Year 2020 Results - News Makers

Nyxoah Reports Full Year 2020 Results - News Makers
newsmakers.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmakers.pk Daily Mail and Mail on Sunday newspapers.

Nyxoah Reports Full Year 2020 Results

Nyxoah Reports Full Year 2020 Results
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021

Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021 Nyxoah to Delay Full Year 2020 Earnings Release Until April 9, 2021 Mont-Saint-Guibert, Belgium - 2 April 2021 - Nyxoah SA (Euronext Brussels: NYXH) ( Nyxoah or the Company ), a medical technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announced that it will delay its full year 2020 earnings release and subsequent conference call, previously scheduled for April 6, 2021. The Company now intends to report full year financial results for the year ended December 31, 2020 on Friday, April 9, 2021, before the market opens. The Company will host a conference call to discuss full year 2020 financial results on the same day at 3:00 p.m. CET / 9:00 a.m. ET. The details for the conference call can be found below. The delay is required for the Company and its auditors to complete final audit procedures in accordance with PCA

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.